Skip to content

Ondansetron Effect on Pain Relief After Laparoscopic Cholecystectomy

Efficacy of Intraperitoneal Ondansetron Administration on Pain Relief After Laparoscopic Cholecystectomy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04468685
Enrollment
50
Registered
2020-07-13
Start date
2020-07-15
Completion date
2020-12-18
Last updated
2021-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis

Brief summary

Laparoscopic cholecystectomy (LC) is an easy procedure characterized by its minimal invasiveness, less post-operative pain and early recovery when compared to the open conventional cholecystectomy. However, patients who have undergone LC still complain of postoperative pain. It has been reported that ondansetron produces numbness when injected under the skin and has local anesthetic effect that is 15 times more potent than lidocaine the most widely used local anesthetic and probably explains its antiemetic action. It possesses anti-inflammatory, anesthetic, and analgesic properties by its multifaceted actions as a 5-HT3 receptor antagonist, a Na channel blocker, and a mu-opioid agonist which may have a potential role in decreasing pain. The study aimed to demonstrate the effectiveness of IP administration of ondansetron on pain management post LC.

Interventions

DRUGOndansetron

Interperitoneal administration in the gall bladder bed

DRUGNormal saline

Interperitoneal administration in the gall bladder bed

Sponsors

National Hepatology & Tropical Medicine Research Institute
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients who are scheduled to undergo elective LC

Exclusion criteria

* Patients undergoing chronic pain treatment * Previous allergic response to local anesthetics or 5-HT3 receptor antagonists * Patients who received analgesics or sedatives 24 h before scheduled surgery

Design outcomes

Primary

MeasureTime frame
change in postoperative pain between the two groups using visual analogue score (VAS)24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026